RXO Current Cash

The latest current cash for RXO is $21M as of March 2026. That compares with $16M in the prior-year period — up 31.3% year over year. Investors often review this figure alongside RXO's historical trend and sector peers before judging valuation or financial health.

Over the past year, RXO's current cash moved from $16M to $21M — a 31.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RXO's operating scale or balance-sheet position.

A current cash figure of $21M for RXO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RXO's current cash ($21M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.